Researchers have identified specific risk factors for anxiety and depression in AD patients.

Ivarmacitinib has been shown to be effective and safe in treating adolescent and adult patients with AD.

Image by Standl M. et al. CC:BY Findings from a new study suggest early-life exposure to domestic dogs may modify the effect of one...

Patients with moderate-to-severe AD experience significant disease burden with physical, emotional, and social impact.

Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...

Children with early-onset pediatric AD have an increased incidence for uveitis.

Mark your calendar for the 2025 edition of the Summit on Atopic Dermatitis virtual conference on May 10, from 10:00 a.m. to 1:00 p.m....

Dr. Christine Neagoe and Dr. Mohannad Abu-Hilal recently discussed the management of AD through topical and systemic treatments.